Cardio-renal syndrome type 5: epidemiology, pathophysiology, and treatment

Sachin S Soni1, Claudio Ronco, Rupesh Pophale

  • 1Department of Nephrology, Mahatma Gandhi Mission Medical College, Aurangabad, India. dr_sachinsoni@yahoo.com

Seminars in Nephrology
|February 28, 2012
PubMed

Insights

Cardio-renal syndromes (CRS) involve heart and kidney dysfunction. Type 5 CRS, affecting systemic conditions, presents unique challenges due to limited research on its clinical course and treatment.

Area of Science:

  • Cardiology
  • Nephrology
  • Systemic Diseases

Background:

  • Cardio-renal syndromes (CRS) are defined as heart or kidney dysfunction impacting the other organ.
  • Five types of CRS have been systematically defined, including acute and chronic cardio-renal and renocardiac syndromes.
  • Type 5 CRS describes cardio-renal involvement in systemic conditions, characterized by concomitant renal and cardiovascular dysfunction.

Purpose of the Study:

  • To systematically define cardio-renal syndromes (CRS) and their subtypes.
  • To describe Type 5 CRS as a distinct clinical and pathophysiological entity.
  • To highlight the limited information available on Type 5 CRS epidemiology, clinical course, and treatment.

Main Methods:

  • Systematic definition and classification of cardio-renal syndromes.
  • Identification of Type 5 CRS as a distinct entity within systemic conditions.
  • Literature review to assess current knowledge on Type 5 CRS.

Main Results:

  • Five types of CRS have been defined, encompassing acute and chronic interactions between heart and kidney.
  • Type 5 CRS is identified as a condition with simultaneous renal and cardiovascular dysfunction, often linked to systemic diseases.
  • Current understanding of Type 5 CRS is limited, with scarce data on its epidemiology, clinical course, and treatment.

Conclusions:

  • CRS represents a spectrum of heart and kidney interactions.
  • Type 5 CRS, while not strictly fitting the initial CRS definition, is a crucial entity in systemic diseases.
  • Further research is essential to elucidate the epidemiology, clinical course, and optimal treatment strategies for Type 5 CRS.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...